A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer-Reference-Cited by-同舟云学术

A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer

Published:2017-08 Issue: Volume:400 Page:79-88
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wu Yuan-Hua,Hong Chi-Wei,Wang Yi-Ching,Huang Wei-Jan,Yeh Ya-Ling,Wang Bour-Jr,Wang Ying-Jan,Chiu Hui-Wen

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. Triple-negative breast cancer;Foulkes;N. Engl. J. Med.,2010

2. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc. Natl. Acad. Sci. U. S. A.,2003

3. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2016

4. Lysine acetylation targets protein complexes and co-regulates major cellular functions;Choudhary;Science,2009

5. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells;Mao;Cell Cycle,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hernandonine-mediated autophagic cell death in hepatocellular carcinoma: Interplay of p53 and YAP signaling pathways;Free Radical Biology and Medicine;2024-09

2. The efficacy and safety of chidamide in combination with etoposide and glucocorticoids for the treatment of hemophagocytic lymphohistiocytosis in adult patients: an open-label, single-center study;Frontiers in Immunology;2024-07-08

3. Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors;Signal Transduction and Targeted Therapy;2023-09-25

4. Development of an ubiquitin‐proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple‐negative breast cancer;The Journal of Gene Medicine;2023-08-22

5. E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies;Frontiers in Immunology;2023-07-11